4/A
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-010539
Options or other derivatives
- CHIEF FINANCIAL OFFICER acquired 12,462 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Alam Kamran CHIEF FINANCIAL OFFICER | 2023-05-31 | Grant or award · Employee Stock Option (right to buy) | +12,462 | 12,462 | D | ||
Loading xslF345X05/form4a-04102025_040408.xml…